Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.14
BATS BZX Real-Time Price
As of 2:18pm ET
 -0.265 / -1.52%
Today’s Change
8.31
Today|||52-Week Range
24.43
-17.54%
Year-to-Date
Implied Volatility Surging for Valeant (VRX) Stock Options
9:30am / Zacks.com - Paid Partner Content
Francis Chou Dumps Bankrupt Sears Canada, Valeant Shares
Apr 12 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close17.40
Today’s open17.47
Day’s range16.92 - 17.61
Volume329,271
Average volume (3 months)13,780,126
Market cap$5.4B
Data as of 2:18pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-21.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-9.82%
P/E ratio2.5
Price/Sales0.84
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.65+0.67%
ACADACADIA Pharmaceutica...-0.52-2.60%
TAROTaro Pharmaceutical ...-0.68-0.67%
----
Data as of 2:18pm ET, 04/19/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$8.7B
Annual profit (last year)$2.4B
Net profit margin27.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts